GlassScriptPhysician profile
Avigeet Gupta
NPI 1588286694
$2,599.11
in general payments reported to CMS, 2019-2025
11 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.05 · 2021: $245 · 2022: $164 · 2023: $507 · 2024: $1,139 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,170.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $434.73 | 2024-2025 | Stealthstation S8 Platform |
| Integra Lifesciences Corporation | $297.42 | 2024 | Acclarent Aera, Trudi Probe, Inspira Air |
| Stryker Corporation | $267.47 | 2022-2024 | Vsp System, Vsp Cranial, Na |
| Olympus America INC. | $267.23 | 2023 | Rhino-Laryngo Videoscope, Diego |
| Intersect Ent, INC. | $264.51 | 2020-2021 | |
| Axogen | $255.56 | 2024-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Connector |
| Acera Surgical, INC. | $220.07 | 2023-2024 | Restrata Wound Matrix |
| Aerin Medical INC. | $217.51 | 2025 | |
| Kerecis Limited | $159.13 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Regeneron Healthcare Solutions, INC. | $154.83 | 2023-2025 | Dupixent |
| Grace Medical, INC. | $60.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avigeet Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.